Lonapalene

N/A

Report date: 2022/05/18 17:42:08
NME

Base Information

Drug NameLonapalene
Drug Alias Name氯萘帕林RS-43179
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionArachidonate 5-lipoxygenase inhibitors
TargetsArachidonate 5-lipoxygenase
Therapy Area/IndicationsPsoriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstrazeneca Pharmaceutical Co LtdF. Hoffmann-La Roche Ltd
Active IndicationsN/A
Inactive IndicationsPsoriasis

Other Information

ATC CodeN/A
Related LinksKEGG